Lawrence Liberti BSc, MSc, RAC

Adjunct Research Professor, Regulatory Affairs and Quality Assurance Graduate Program, Temple University School of Pharmacy

Dr Liberti has worked in the fields of pharmaceutical regulatory affairs, communications and clinical R&D for the past four decades. He began his career at Wyeth Laboratories working in product development, then as a regulatory writer in clinical R&D, and manager of safety surveillance in medical affairs. He served as the editorial director for the North American operations of ADIS international after which he founded PIA Ltd, a company specialising in regulatory writing and consulting; he co-founded Astrolabe Analytica under which he helped develop, patent and commercialise the Astrolabe Message Mapping System.TM
From 2009 to 2019 he has served as the Executive Director of CIRS (the Centre for Innovation in Regulatory Science, and from 2019 to 2021 as Head of Regulatory Collaborations. From 2021 he has served as an adjunct in the graduate school of pharmacy, Temple University. He has been actively involved in promulgating best practices in the regulatory aspects of medicines development, especially in the emerging markets. He is a
volunteer Director of the Erudee Foundation, a non-profit which has as its goals supporting local post-secondary educational opportunities in the health sciences for students in the Caribbean and East Africa and to inform the effective use of healthcare systems.
Dr Liberti received his doctorate in International Regulatory Policy through the WHO Collaborating Centre for Pharmaceutical Policy and Regulation based in the Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands, where his research centred on expedited
regulatory pathways with applicability in the emerging markets. He received both his Bachelor of Science in pharmacy and Master’s degree in
pharmacognosy from the Philadelphia College of Pharmacy and Science (now the University of the Sciences in Philadelphia). He was awarded an honorary Doctor of Science degree by his alma mater. He attained the status of Regulatory Affairs Certified (RAC) with the Regulatory Affairs Professional Society and serves on its Board of Directors. He is a Fellow of the American Medical Writers Association and is a recipient of their Golden Apple award for excellence in teaching. He serves as a member of the Board of Directors of the Regulatory Affairs professional Society (RAPS).